SARS-CoV-2 may pose an occupational health risk to healthcare workers. Here, we report
the seroprevalence of SARS-CoV-2 antibodies, self-reported symptoms and occupational …

Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal
characteristics of antibodies targeting various antigens after asymptomatic to mild COVID-19 …

Background Emerging data support detectable immune responses for months after severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and vaccination, but it is …

Objective The COVID‐19 pandemic poses an immense need for accurate, sensitive and
high‐throughput clinical tests, and serological assays are needed for both overarching …

New biomarkers of Alzheimer’s disease (AD) with a diagnostic value in preclinical and
prodromal stages are urgently needed. AD-related serum autoantibodies are potential candidate …

Autoimmune processes are suspected to play a role in the pathophysiology of psychotic
disorders. Better understanding of the associations between auto-immunoglobulin G (IgG) …

Protein profiling enabled through affinity proteomics represents a powerful strategy for
analysis of complex samples such as human body fluids. Cerebrospinal fluid (CSF) is the …

Numerous assays evaluating serological and cellular responses have been developed to
characterize immune responses against SARS-CoV-2. Serological assays are both cost- and …

The diagnostic criteria for schizophrenia (SCZ) and bipolar disorder (BD) are based on
clinical assessments of symptoms. In this pilot study, we applied high-throughput antibody-based …

The extent that antibodies to SARS-CoV-2 may protect against future virus-associated disease
is unknown. We invited all employees (n = 15,300) at work at the Karolinska University …